CLINICAL_TRIALS
trial_result
· 2007-09-20
Clinical Trial Update: Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis [NA]
Summary
Clinical trial update on the effectiveness of the selective serotonin reuptake inhibitor citalopram (Cipralex) for prurigo nodularis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hadassah Medical Organization | Conditions: Prurigo Nodularis | NA | Status: UNKNOWN